Kyntra Bio, Inc. Stock Analysis & AI Score
Kyntra Bio, Inc. (KYNB) has an ST Score of 47.5 (C+), driven by its Forecast (A) and held back by its Valuation (D+). Analysts rate it Hold with a $28.00 price target (+300.0% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Kyntra Bio, Inc. (KYNB) has an ST Score of 47.5 (C+), driven by its Forecast (A) and held back by its Valuation (D+). Analysts rate it Hold with a $28.00 price target (+300.0% upside).
- Strongest
- ForecastA
- Weakest
- ValuationD+
All factor grades
- ForecastA
- MomentumB-
- ProfitabilityC
- Financial StrengthC
- GrowthC-
- ValuationD+
- Piotroski5/9
Contact
KYNB stock: frequently asked questions
What is KYNB's ST Score?
Kyntra Bio, Inc. (KYNB) has an ST Score of 47.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is KYNB a buy, hold, or sell?
Analysts rate KYNB a Hold, with a price target of $28.00 (+300.0% vs the current price). Our ST Score grades it C+ (47.5/100). The ST Score is a data-driven signal, not a recommendation.
What are KYNB's factor grades?
Valuation D+, Profitability C, Financial Strength C, Momentum B-, Growth C-, Forecast A.
What is KYNB's valuation grade?
Kyntra Bio, Inc. (KYNB) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is KYNB's growth grade?
Kyntra Bio, Inc. (KYNB) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is KYNB's profitability grade?
Kyntra Bio, Inc. (KYNB) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is KYNB's financial strength grade?
Kyntra Bio, Inc. (KYNB) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for KYNB?
The average analyst price target for Kyntra Bio, Inc. (KYNB) is $28.00 from 15 analysts, which is +300.0% versus the recent price of $7.00.
What is KYNB's Piotroski score?
Kyntra Bio, Inc. (KYNB) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.